Roberta Bitti

Research activity per year

Efficacy and safety of switching from reference adalimumab to SB5 in a real-life cohort of inflammatory rheumatic joint diseases.
Bruni, C., Bitti, R. (Co-author), Nacci, F., Cometi, L., Tofani, L., Bartoli, F., Fiori, G. & Matucci-Cerinic, M., 2021, In: CLINICAL RHEUMATOLOGY. 40, 1, p. 85-91
Research output: Contribution to journal › Original Article (Journal) › peer-review

17 Citations (Web of Science)

Research output